Treatment with a single vaginal suppository containing 15-methyl PGF2α methyl ester at expected time of menstruation
- 1 March 1979
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 17 (3) , 469-481
- https://doi.org/10.1016/s0090-6980(79)80015-5
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Abortion in early pregnancy by vaginal administration of 16,16-dimethyl-PGE2 in comparison with vacuum aspirationContraception, 1977
- Development of a vaginal suppository suitable for single administration for interruption of second trimester pregnancyContraception, 1977
- Interruption of First Trimester Pregnancy by ProstaglandinsInternational Journal of Gynecology & Obstetrics, 1977
- Work in progress menstrual induction with PGF2α and PGE2Prostaglandins, 1975
- Prostaglandin F2α (PGF2α) and prolactin secretion in ratsProstaglandins, 1975
- Prostaglandin Involvement in Hypothalamic Control of Gonadotropin and Prolactin ReleaseScience, 1973
- The prospects of PGs in postconceptional therapyProstaglandins, 1973
- Plasma Steroid and Luteinizing Hormone Levels during Prostaglandin F2 Administration in Luteal Phase of Menstrual CycleBMJ, 1972
- Intravenous infusion of prostaglandin F2α in the mid-luteal phase of the normal human menstrual cycleProstaglandins, 1972